1 August 2021 in Journal of Hepatology
To evaluate the association between muscle mass and fatty infiltration and biopsy-assessed NAFLD in patients with obesity. At inclusion (n=184) and 12 months after a dietary intervention (n=15) or a bariatric surgery (n=24), we evaluated NAFLD with liver biopsy, skeletal muscle mass index with computed tomography (CT-SMI) and bioelectrical impedance analysis (BIA-SMI). We developed an index to evaluate absolute fat content in muscle (skeletal muscle fat index; SMFI) from CT-based psoas muscle density (SMFIPsoas). Muscle mass was higher in patients with NAFLD than in those without (CT-SMI 56.8±9.9 vs 47.4±6.5 cm2/m,2 p<0.0001). There was no association between sarcopenia and NASH. SMFIPsoas was higher in NASH ≥F2 and early NASH F0-1 than in NAFL (78.5±23.6 and 73.1±15.6 vs 61.2±12.6, p<0.001). One point in score for any of the individual cardinal NASH features (i.e. steatosis, inflammation or ballooning) associated with an increase in SMFIPsoas (all p<0.05). The association between SMFIPsoas and NASH was highly significant even after adjustment for multiple confounders (all p<0.025). After intervention (n=39), NASH improvement, defined by NAS <3 or 2-point NAS score reduction, was achieved in more than 75% of patients (n=25 or n=27, respectively) that had pre-established NASH at inclusion (n=32) and associated with a significant decrease in SMFIPsoas (p<0.001). Strikingly, all patients who had ≥11% reduction in SMFIPsoas achieved NASH improvement (14/14, p<0.05). Muscle fat content, but not muscle mass, is strongly and independently associated with NASH. All individuals who achieved a ≥11% decrease in SMFIPsoas after intervention improved their NASH. These data call to explore muscle fatty infiltration as a potential marker for (and perhaps a pathophysiological contributor to) NASH. The fat content in skeletal muscles is highly reflective of the severity of non-alcoholic fatty liver disease (NAFLD) in patients with morbid obesity. In particular, muscle fat content is strongly associated with non-alcoholic steatohepatitis (NASH) and decreases upon NASH improvement. These data call to explore muscle fatty infiltration as a potential marker and perhaps a pathophysiological contributor to NASH.
23 May 2023 in Journal of Hepatology
1 June 2021 in Clinical Nutrition ESPEN
2 January 2024 in Clinical Nutrition ESPEN
28 April 2009 in Endocrine
15 May 2021 in Endocrine Abstracts
Background and aims Low levels of testosterone and non-alcoholic fatty liver disease (NAFLD) in obese men are both linked to the metabolic syndrome, but the independent association between testosterone and NAFLD needs to be elucidated. In this cross-sectional analysis the association between total testosterone (total T) and calculated free testosterone (cFT) on the one hand and NAFLD, non-alcoholic steatohepatitis (NASH) and fibrosis on the other hand was investigated in obese men. Methods Data of 134 men of 18 years or older and a body mass index of at least 25 kg/m2 who underwent a liver biopsy after visiting the obesity clinic were collected. Liver biopsy was performed if there was suspicion of NAFLD. Individuals were classified into 4 categories: no NAFLD, NAFL, NASH (no fibrosis (F0) or F1) or NASH with advanced fibrosis (F2-F4). Because of an unequal distribution of fibrosis, the 5 stages were regrouped into F01 and F24. Results Mean age was 45 ± 12, median BMI was 39.6 kg/m2 (range 25.064.9). Only 5.2% of the individuals had no NAFLD. Of the individuals with NAFLD, 15.7% had NAFL, 56.7% had NASH F0-F1 and 22.4% had NASH F2-F4. Fibrosis stage 0 to 4 were present in respectively 47.8, 26.9, 17.2, 7.5 and 0.7%. cFT and total T were below the limit of normal in respectively 63% and 23% of individuals. One-way ANOVA showed a tendency toward a difference in the level of cFT between the grades of NAFLD (P = 0.053) that did not persist after controlling for confounding variables. No significant difference was seen for total T. Ordinal regression analysis showed a decreasing level of cFT was associated with an increase in the grade of NAFLD (P = 0.005) that did not persist after controlling for confounding variables. No significant effect of total T on the grade of NAFLD was seen. When performing the same analyses for fibrosis and after controlling for confounding variables, no difference in the level of cFT or total T were seen between F0-F1 and F2-F4 and no effect of cFT or total T was seen on the stage of fibrosis. Conclusion To the best of our knowledge, this is until now the largest study investigating the association between sex steroid levels and biopsy-proven NAFLD. After controlling for confounding variables no association was found between the level of total T and cFT on the one hand and NAFLD, NASH or fibrosis on the other hand.